A biological marker for normal pressure hydrocephalus (NPH) is beneficial f
or evaluation of its severity and of indications for shunt operation. Tau p
rotein was initially considered as a biological marker in cerebrospinal flu
id (CSF) from Alzheimer's patients. Recently, it has been demonstrated that
degeneration in the brain causes elevation of tau in CSF. Therefore, the t
au level in CSF from NPH patients was evaluated. Tau levels in CSF from NPH
patients were significantly higher than that in controls. The tau levels w
ere correlated with the severity of dementia, urinary incontinence, and gai
t disturbance in NPH. These results suggest that CSF tau may be useful as a
biological marker for NPH to determine the level of neuronal degeneration.